Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Getting positioned for the O&G DDR wave rolling in

Cleanaway Waste Management
3:27pm
March 21, 2025
While we prefer CWY to deploy capital into its leading Solid Waste Services segment, we do find attributes of the CR acquisition appealing given the price paid and how it helps CWY get positioned for the wave of oil & gas decommissioning, decontamination and remediation work expected to eventuate over time. CWY's recent share price decline improved its value attraction. While the stock has lifted off these recent lows we think there is more to come and upgrade to ADD. 12 month target price upgraded to $2.95 (+4%). Potential TSR c.14%.

Eyes on the prize

ALS Limited
3:27pm
March 21, 2025
The shares have underperformed this week as attention has turned to pricing pressure in geochemistry (not new), geochemistry volumes merely seeing “green shoots” (before commencement of the main drilling season in the Northern Hemisphere), and potential negative impacts on the US Environment business due to the Trump administration (not material). This has raised questions about ALQ’s ability to meet FY25 expectations. We believe this is misguided. Volumes in geochemistry have ticked up (albeit only slightly) and there should be a material swing in FX from 1H (-$15m EBIT) to 2H (positive FX). Consensus is forecasting 2H EBIT ($260m) to be down $5m from 1H constant FX EBIT ($265m). At the same time, the backdrop for the key Commodities business continues to improve. The stock is trading on 21x FY26F PE which is well below IMD (26x) and not reflective of the outlook. We see recent weakness as a buying opportunity. Target price moves to $17.50 (from $16.75).

Strategic re-alignment and capital raise

Micro-X
3:27pm
March 21, 2025
MX1 has moved its focus to medical imaging for its cold cathode x-ray technology, with further work on the Argus being halted after the commercial launch didn’t attract sufficient customer interest. We are supportive of this pivot. A strategic investment, a capital raise and project income from ARPA-H help replace the lost revenue from the Argus and improve the cash position to enable MX1 to realign its business focus. Our TP reduces to A$0.17 (was A$0.19) We maintain our Speculative Buy recommendation.

Start of the next era

Sigma Healthcare Ltd
3:27pm
March 20, 2025
SIG posted its final result as a stand-alone company which was in line with guidance. We now move to adjust our model to fully reflect the merged entity with a June Year End, which sees a modest increase in our forecasts. As a result, our valuation has increased slightly to A$2.40 (was A$2.31). We have maintained a 30% liquidity premium reflecting expected passive buying from index funds to derive our target price of A$3.12. We maintain our Add recommendation for clients looking for a quality growth company.

Cyclical trough approaching

Brickworks
3:27pm
March 20, 2025
As largely foreshowed in the 11-March trading update, BKW’s 1H25 result was weak, as Property saw EBITDA (ex-revals) decline on the back of lower development profits, whilst Building Materials was impacted by lower demand and Investments saw a slight moderation in investment returns. Nonetheless, BKW was able to increase the dividend 1 cps to 25 cps (in line with our forecasts). As we look forward, we struggle to see catalysts for BKW, with investment market uncertainty likely to outweigh any potential tailwinds from industrial real estate rental income. We retain our Hold rating, with a $26.50/sh price target.

FDA approval for CORIS……. finally

Nanosonics
3:27pm
March 20, 2025
The long-awaited approval for NAN’s flexible endoscope CORIS has been received, derisking the opportunity to diversify and expand and further embed itself as a disinfection solutions leader within the hospital. The flexible endoscope market presents a significant opportunity, and we view CORIS as having strong potential given its advantages over current standards. However, adoption rates are typically not linear so further updates over the coming 12 months will aid the shaping of market expectations. We raise our valuation and target price to A$5.50 (from A$4.50) following reduced risks post-approval. This remains a strong business with a dominant market position, high-margin recurring revenue, and potential for further market penetration. Remains a key stock to watch.

Share price weakness provides buying opportunity

Judo Capital Holdings
3:27pm
March 20, 2025
Since February JDO’s share price has drifted lower alongside its banking sector peers, and then stepped down today with the overnight block trade exit of two pre-IPO investors. We take this share price weakness as a buying opportunity. Nothing fundamentally has changed in the business as a result of these shareholder exits. Upgrade to ADD with potential TSR at current prices of c.21%. No change to forecasts or DCF-based target price of $2.08.

Investing for growth requires patience

Webjet Group Limited
3:27pm
March 19, 2025
WJL has reiterated its FY25 guidance, however FY26 is now a year of investment and not acceleration. We have made material revisions to our FY26 forecasts. With its Strategy Presentation, WJL has laid out its 5-year growth plan which is targeting to double TTV by FY30 (materially above consensus estimates). Its strategy is all about capturing the full travel wallet through higher margin ancillary product sales and selling more international vs domestic travel. It also includes offering a more tailored business travel offering. The strategy requires a brand refresh and increased investment in technology, capability and marketing. While the size of the opportunity is material if WJL delivers on its target, execution risk is high. Despite its undemanding fundamentals, given earnings growth is not expected until FY27, WJL is now lacking near term catalysts, in the absence of capital management and/or corporate activity. We move to a Hold rating.

Resetting the business for growth

Myer
3:27pm
March 19, 2025
MYR’s 1H25 result was impacted by the challenging consumer environment as well as operational issues at its National Distribution Centre (NDC). These issues were flagged at the five-month trading update in January. Sales were broadly flat yoy at $1.8bn, while gross profit margin was down ~50bps driven by mix shift, DC costs and increased promotional activity. EBIT was negatively impacted by $12m due to operational issues at the NDC. NPAT was down 18% yoy to $42.4m. MYR has completed a strategic review, a new leadership team has been put in place to drive the growth strategy moving forward. The combination with Apparel Brands has been completed with the group to record combined results from 2H25.

Well placed to weather the cycle lows

New Hope Group
3:27pm
March 18, 2025
NHC’s 1H25 result was typically solid with capital management the key surprise. The 1H dividend materially beat expectations, and we like the optionality to accrete EPS/value through current weakness via the new on-market buyback. Maintained FY25 guidance offers comfort amid weaker prices, supporting NHC’s cost and margin advantages versus key peers. NHC remains too cheap here, but the sluggish thermal coal outlook is challenging price floors the into shoulder season and NHC does lack a near-term catalyst.

News & Insights

The US economy is growing strongly at 2.34% in Q2 2025 but is expected to slow to 1.4% in 2025, with falling interest rates and a weaker US dollar likely to boost commodity prices, benefiting Australian markets. Michael Knox discusses.

We think the US economy is currently experiencing solid growth, with data from the Chicago Fed  National Activity Index indicating an annual growth rate of just above  2%. This aligns with projections from other parts of the Federal Reserve System, such as the New York Fed. The New York Fed’s weekly Nowcast, updated every Friday, estimates that for the second quarter of 2025, the US economy is growing at an annualised rate of 2.34%, surpassing the 2% mark. This robust growth is consistent with our model’s view that the US economy is now performing strongly. However, we anticipate a slowdown in the second half of 2025.

On 18 June the Fed released its Summary of Economic Projections  with the Federal Reserve’s  forecasting US GDP growth to drop to 1.4% in 2025, down from their March estimate of 1.7%. Looking further ahead, growth is expected to pick up slightly to 1.6% in 2026 and 1.8% in 2027, aligning with the long-term trend growth rate of around 1.8%. We believe this recovery trend could be even  higher,  driven by reduced regulation under the second Trump administration and aggressive tax write-offs for companies building factories in the US, allowing 100% write-offs for equipment and buildings in the first year. This policy should foster stronger systemic growth.

Economic Projections of the Federal Reserve

The Fed expects that as the economy slows,  unemployment is projected to rise to 4.5% from the current level of 4.2%. Inflation, measured by the Consumer Price Index (CPI), is running at 3.5% this year, approximately 50 basis points higher than the Personal Consumption Expenditures (PCE) index of 3.0%, with 1.6% of this  inflation  attributed to tariffs. The Fed expects PCE Inflation  to ease to 2.4% in 2026 and 2.1% in 2027. The Federal Reserve anticipates cutting the effective  federal funds rate, currently at 433 basis points (according to the New York Fed), by 50 basis points by the end of 2025, followed by an additional 25 basis points in each of the next two years. This aligns with our own Fed Funds rate  model’s current equilibrium federal funds rate of  3.85% . The Fed Outlook  supports our scenario of a slowing US economy and rate cuts in the second half of 2025 and beyond. A falling US dollar is then expected to exert upward pressure on commodity prices, benefiting Australian Equity markets.

Taking questions during the Press Conference after releasing the Fed statement  ,Federal Reserve Chair Jay Powell,   addressed the certainty and uncertainty surrounding the inflationary effects of tariffs. Initially, at the start of 2025, the inflationary impact of tariff policies was unclear, but three months of favourable inflation data have provided this clarity, indicating that the inflationary effects are less severe than anticipated. Powell noted that the Feds own uncertainty on the inflationary effects of  tariffs  peaked in April 2025, and the Federal Reserve now has a clearer understanding that  the inflation effects, are lower than initially expected.

The Fed view  supports our own scenario of a slowing US economy in the second half of 2025, allowing for Fed rate cuts  . This in turn should then lead to  a falling US dollar, which we in turn  expect to drive rising commodity prices.

Read more
The Your Wealth publication is our half yearly scrutiny into current affairs for wealth management. Our latest Issue 29 is out now.

The second half of 2025 will be an interesting time for everyone. Geopolitical uncertainty prevails. How will all of this impact the Australian investor and in particular, their wealth and retirement savings? Whether you are an accumulator, saving for short- and long-term goals, or a retiree, hoping for a comfortable retirement, the ability to manage this uncertainty will be key.

When we published the previous Your Wealth – First Half 2025, the Division 296 Bill (Div296) was also facing uncertainty. The Bill was eventually blocked in the Senate prior to the Federal Election. The Labor Party succeeded in winning so it’s Ground Hog Day for Div296. The Government doesn’t have the numbers in the Senate to pass the Bill without support from other parties. The Greens are the likely negotiating party but will undoubtably have their own agenda. Regardless, there is a high probability this legislation will be passed once Parliament resumes.

Our message to our clients is to wait until we know more details and to not act in haste.

In addition to our Feature Article which provides further insights on Div296, this edition also Spotlights the Aged Care changes due this year, with the start date pushed back to 1 November.

We hope readers enjoy this edition of Your Wealth.


Morgans clients receive exclusive insights such as access to our latest Your Wealth publication. Contact us today to begin your journey with Morgans.

      
Contact us
      
Read more
Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more